GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » United Laboratories International Holdings Ltd (FRA:UNJ) » Definitions » Market Cap

United Laboratories International Holdings (FRA:UNJ) Market Cap : €2,051 Mil (As of Apr. 28, 2024)


View and export this data going back to 2007. Start your Free Trial

What is United Laboratories International Holdings Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). United Laboratories International Holdings's share price for the quarter that ended in Jun. 2023 was €0.74. United Laboratories International Holdings's Shares Outstanding (EOP) for the quarter that ended in Jun. 2023 was 1,817 Mil. Therefore, United Laboratories International Holdings's market cap for the quarter that ended in Jun. 2023 was €1,345 Mil.

United Laboratories International Holdings's quarterly market cap increased from Jun. 2022 (€981 Mil) to Dec. 2022 (€1,018 Mil) and increased from Dec. 2022 (€1,018 Mil) to Jun. 2023 (€1,345 Mil).

United Laboratories International Holdings's annual market cap declined from Dec. 2020 (€1,012 Mil) to Dec. 2021 (€847 Mil) but then increased from Dec. 2021 (€847 Mil) to Dec. 2022 (€1,018 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. United Laboratories International Holdings's Enterprise Value for Today is €1,696 Mil.


United Laboratories International Holdings Market Cap Historical Data

The historical data trend for United Laboratories International Holdings's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

United Laboratories International Holdings Market Cap Chart

United Laboratories International Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,001.23 1,012.21 847.41 1,017.54 1,435.45

United Laboratories International Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 847.41 981.49 1,017.54 1,344.60 1,435.45

Competitive Comparison of United Laboratories International Holdings's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, United Laboratories International Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


United Laboratories International Holdings's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, United Laboratories International Holdings's Market Cap distribution charts can be found below:

* The bar in red indicates where United Laboratories International Holdings's Market Cap falls into.



United Laboratories International Holdings Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

United Laboratories International Holdings's Market Cap for the fiscal year that ended in Dec. 2022 is calculated as

Market Cap (A: Dec. 2022 )=Share Price (A: Dec. 2022 )*Shares Outstanding (EOP) (A: Dec. 2022 )
=€0.56*1817.03
=€1,018

United Laboratories International Holdings's Market Cap for the quarter that ended in Jun. 2023 is calculated as

Market Cap (Q: Jun. 2023 )=Share Price (Q: Jun. 2023 )*Shares Outstanding (EOP) (Q: Jun. 2023 )
=€0.74*1817.03
=€1,345

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


United Laboratories International Holdings  (FRA:UNJ) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


United Laboratories International Holdings Market Cap Related Terms

Thank you for viewing the detailed overview of United Laboratories International Holdings's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


United Laboratories International Holdings (FRA:UNJ) Business Description

Traded in Other Exchanges
Address
No. 6 Fuk Wang Street, Yuen Long Industrial Estate, New Territories, Hong Kong, HKG
United Laboratories International Holdings Ltd is a major drug manufacturing company. United Laboratories is organized into three revenue streams, including Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, insulin series products, and other medicines. The vast majority of the company's revenue is derived from its Bulk medicine segment, followed by Finished products. Most of the company's sales are generated in China, followed by Europe and India.

United Laboratories International Holdings (FRA:UNJ) Headlines

No Headlines